CNSY · Company research
Cerenome, Inc. Common Stock (CNSY): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| New Strong Sell Stocks for October 15th | Stock markets declined following a higher-than-expected CPI inflation report. Three companies were added to the Zacks Rank #5 (Strong Sell) list due to downward earnings estimate revisions: Cadiz Inc., Cerenome Inc., and Context Therapeutics Inc. | View source ↗ | Zacks Investment Research | Oct 15, 2026 | bearish | -1 | 1 |
| New Strong Sell Stocks for October 15th | Stock markets declined following a higher-than-expected CPI inflation report. Three companies were added to the Zacks Rank #5 (Strong Sell) list due to downward earnings estimate revisions: Cadiz Inc., Cerenome Inc., and Context Therapeutics Inc. | View source ↗ | Zacks Investment Research | Oct 15, 2026 | bearish | -1 | 1 |
| Cerenome, Inc. (CNSY) stock price, news, quote and history - Yahoo Finance Singapore | Cerenome, Inc. (CNSY) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 8, 2026 | neutral | 0 | 0.6 |
| Cerenome, Inc. (CNSY) Stock Price, News, Quote & History - Yahoo! Finance Canada | Cerenome, Inc. (CNSY) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 8, 2026 | neutral | 0 | 0.6 |
| After stock grant vesting, Cerenome (CNSY) director Kyle Guse holds 1,843 shares directly. - Stock Titan | After stock grant vesting, Cerenome (CNSY) director Kyle Guse holds 1,843 shares directly. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| After acquiring 921 shares, Cerenome (CNSY) director holds 1,843 shares directly. - Stock Titan | After acquiring 921 shares, Cerenome (CNSY) director holds 1,843 shares directly. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| Three stock grants vest as Cerenome (CNSY) CEO Hedrick acquires 6,387, 8,066 and 1,986 shares. - Stock Titan | Three stock grants vest as Cerenome (CNSY) CEO Hedrick acquires 6,387, 8,066 and 1,986 shares. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| A director acquires 921 shares as Cerenome (CNSY) stock grants vest, bringing direct holdings to 1,843. - Stock Titan | A director acquires 921 shares as Cerenome (CNSY) stock grants vest, bringing direct holdings to 1,843. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| Cerenome plans to discuss billing and access for its spinal-fluid diagnostic platform. - Stock Titan | Cerenome plans to discuss billing and access for its spinal-fluid diagnostic platform. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Tangible book value per share of Cerenome, Inc. – NASDAQ:CNSY - TradingView | Tangible book value per share of Cerenome, Inc. – NASDAQ:CNSY TradingView | View source ↗ | TradingView | Aug 24, 2026 | neutral | 0 | 0.6 |
| Cerenome - CNSY - Stock Price & News - The Motley Fool | Cerenome - CNSY - Stock Price & News The Motley Fool | View source ↗ | The Motley Fool | Aug 16, 2026 | neutral | 0 | 0.6 |
| Cerenome (CNSY) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance | Cerenome (CNSY) Reports Q2 Loss, Misses Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 14, 2026 | neutral | 0 | 0.6 |
| What is the current Price Target and Forecast for Cerenome, Inc. (CNSY) - Zacks Investment Research | What is the current Price Target and Forecast for Cerenome, Inc. (CNSY) Zacks Investment Research | View source ↗ | Zacks Investment Research | Aug 7, 2026 | neutral | 0 | 0.6 |
| Plus Therapeutics (CNSY) Stock Price, News & Analysis - MarketBeat | Plus Therapeutics (CNSY) Stock Price, News & Analysis MarketBeat | View source ↗ | MarketBeat | Aug 6, 2026 | neutral | 0 | 0.6 |
| CNSY Forecast — Price Target — Prediction for 2027 - TradingView | CNSY Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Aug 5, 2026 | neutral | 0 | 0.6 |
| Cerenome (Nasdaq:CNSY) - Stock Analysis - Simply Wall Street | Cerenome (Nasdaq:CNSY) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Aug 4, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Aug 3, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.